Proopiomelanocortin (POMC) neurons are major regulators of energy balance and 26 glucose homeostasis. In addition to being regulated by hormones and nutrients, 27 POMC neurons are controlled by glutamatergic input originating from multiple brain 28 regions. However, the factors involved in the formation of glutamatergic inputs and 29 how they contribute to bodily functions remain largely unknown. Here, we show that 30 during the development of glutamatergic inputs, POMC neurons exhibit enriched 31 expression of the Efnb1 (EphrinB1) and Efnb2 (EphrinB2) genes, which are known to 32 control excitatory synapse formation. In vitro silencing and in vivo loss of Efnb1 or 33
Efnb2 in POMC neurons decreases the amount of glutamatergic inputs into these 34 neurons. We found that mice lacking Efnb1 in POMC neurons display impaired 35 glucose tolerance due to blunted vagus nerve activity and decreased insulin 36 secretion. However, mice lacking Efnb2 in POMC neurons showed no deregulation of 37 insulin secretion and only mild alterations in feeding behavior and gluconeogenesis. 38
Collectively, our data demonstrate the role of ephrins in controlling excitatory input 39 amount into POMC neurons and show an isotype-specific role of ephrins on the 40 regulation of glucose homeostasis and feeding. 41
Introduction 46
Obesity and associated diseases, such as type 2 diabetes, are major public 47 health concerns, and their worldwide prevalence are increasing at an alarming rate. 48
Energy and glucose homeostasis are centrally controlled by complex neuronal 49 networks that involve two main antagonistic neuronal populations in the arcuate 50 nucleus of the hypothalamus (ARH): the anorexigenic proopiomelanocortin (POMC) 51 neurons and the orexigenic Agouti-related peptide (AgRP)/neuropeptide Y (NPY) 52 coexpressing neurons (1) (2) (3) (4) . In addition to the key role they perform in controlling 53 feeding, POMC and AgRP/NPY neurons are involved in the control of glucose 54 homeostasis (5, 6) . Indeed, insulin action on AgRP neurons suppresses hepatic 55 glucose production (7, 8) and chronic activation and inhibition of POMC neurons 56 represses and stimulates gluconeogenesis, respectively (9). Moreover, alterations in 57 POMC signaling, circuits, or neuronal survival are associated with disruption of 58 glucose homeostasis. (10) (11) (12) . 59 POMC and AgRP/NPY neurons are major integrators of peripheral hormones 60 (insulin, leptin, and ghrelin) and nutrients (glucose) to control energy and glucose 61 homeostasis through neuroendocrine and autonomic responses (13) (14) (15) (16) (17) . Besides, 62 POMC and AgRP/NPY neurons also receive abundant central information through 63 GABAergic (inhibitory) and glutamatergic (excitatory) inputs (18) . Notably, POMC 64 neurons primarily receive glutamatergic inputs, whereas AgRP/NPY neurons receive 65 primarily GABAergic inputs (19) . However, the mechanisms underlying the 66 development of POMC neuronal circuits and particularly the formation of 67 glutamatergic inputs and how they contribute to glucose homeostasis and energy 68 balance remain elusive. 69
Results 87
Onset of glutamatergic inputs into POMC neurons 88
To visualize the development of excitatory presynaptic terminals in POMC 89 neurons, we performed immunohistochemical labeling of presynaptic glutamatergic 90 vesicular transporter (vGLUT2) in POMC neurons expressing a tdTomato reporter 91 (Pomc-Cre;tdTomato) in postnatal days P6, P14 and P22 male mice ( Figure 1A) . At 92 P6, glutamatergic inputs were already observed to be in contact with POMC neurons, 93 and the amount of inputs increased gradually until P22 ( Figures 1A-C) . 94
Based on this developmental observation, we next performed transcript 95 profiling of POMC-expressing (POMC + ) and NPY + cells at P14 to identify putative 96 genes involved in glutamatergic synapse formation (Figures 1D and 1E) . POMC 97 progenitors can give rise to NPY neurons or POMC neurons. We thus performed 98 RNA-sequencing (RNA-seq) experiments on POMC neurons (i.e., POMC->POMC), 99 on NPY neurons derived from POMC progenitors (i.e., POMC->NPY), or on NPY 100 neurons not derived from POMC progenitors (i.e., NPY->NPY). These three 101 subpopulations can be separated based on their fluorescence when using Pomc-102
Cre;tdTomato;Npy-hrGFP animals (red cells: POMC->POMC; yellow cells: POMC-103 >NPY cells; and green cells: NPY->NPY) (Figures 1D-G, S1A and S1B). Principal 104 component analysis (PCA) of the RNA-seq data did not distinguish POMC->NPY 105 from NPY->NPY neuronal subpopulations ( Figure S1A ). We therefore only focused 106 on results obtained from POMC->POMC and NPY->NPY neurons. This analysis 107 revealed that 1586 genes were upregulated, and 1202 genes were downregulated in 108 POMC->POMC neurons compared to NPY->NPY neurons. However, when the 109 analysis was restricted to genes involved in axon guidance ( Figure S1B , Table S1 ), 110 out of the 37 identified genes, 2 were significantly upregulated and 4 were 111 downregulated in POMC neurons compared to NPY neurons. In particular, Efnb1 and 112 Efnb2 were 5.2-and 16-fold enriched, respectively (Figures 1F, 1G and Figure S1B) . 113
We further confirmed this increase in Efnb1 and Efnb2 mRNA expression in POMC 114 neurons using RT-qPCR and observed consistent results; there was a 5. 2-and 5.8-115 fold increase in Efnb1 and Efnb2 mRNA, respectively ( Figures 1H and 1I To study whether EphrinB1 and EphrinB2 can directly modulate the number of 126 glutamatergic terminals on POMC neurites, we had to identify the glutamatergic area 127 innervating the POMC neurons. Previous monosynaptic retrograde mapping showed 128 that POMC neurons receive inputs from several sites, such as the preoptic area, the 129 bed nucleus of the stria terminalis, the lateral septum and, in particular, from the PVH 130
We combined the detection of retrogradely labeled mCherry-positive cells with in situ 137 hybridization of vglut2 mRNA. This allowed us to visualize PVH cells that were 138 retrogradely labeled with mCherry and were glutamatergic ( Figure S2 ). These 139 observations confirmed that POMC neurons receive glutamatergic inputs from the 140
PVH. 141
We next examined whether ephrin receptors EphB1, EphB2, EphB3, EphB4, 142
EphA4 and EphA5 were expressed in the PVH when glutamatergic terminals 143 developed in POMC neurons (from P8 to P18). We found that Ephb1, Ephb2 ( Figure  144 2A), Ephb3, Ephb4, Epha4 and Epha5 mRNA ( Figure S3 ) were expressed in the 145 PVH during this postnatal period. Ephb1 and Ephb2 are well-known receptors of 146 EphrinB1 and EphrinB2 (21). We thus assessed by in situ hybridization whether 147
Ephb1 and Ephb2 mRNA were specifically expressed by glutamatergic neurons of 148 the PVH at P14. Our results show that 97.2% and 88.2% of glutamatergic neurons in 149 the PVH expressed Ephb1 and Ephb2, respectively (Figures 2B and 2C) . These data 150 suggest that the establishment of PVH glutamatergic input into POMC neurons may 151 depend on presynaptic EphB receptors and postsynaptic EphrinB ( Figure 2D ). 152
To confirm that Efnb1 and Efnb2 expressed by POMC neurons were required 153 for the establishment of glutamatergic inputs, we used a primary co-culture cell 154 system. PVH and ARH cells were isolated from Pomc-eGFP mouse cells and were 155 maintained in culture conditions that enable the formation of neuronal networks 156 ( Figure 3A ). Efnb1 or Efnb2 siRNA-based silencing led to an 83% and 84% decrease 157 in Efnb1 and Efnb2 mRNA expression, respectively, ( Figure 3B) also be found ( Figure S4A ); nonetheless, Efnb1 mRNA was expressed in adult 173 pituitary ( Figure S4B and S4C). However, the deletion of Efnb1 in POMC neurons did 174 not affect the expression of Efnb1 or Efnb2 mRNA in the adult pituitary (Figures S4B 175 and S4C) . 176
Next, we examined whether the lack of Efnb1 in POMC neurons caused 177 disturbances in body weight and food intake. The postnatal growth curves (body 178 weights) and body composition of Pomc-Cre;Efnb1 loxP/0 mice were undistinguishable 179 from Efnb1 loxP/0 control male mice (Figures 4D and 4E) . Consistent with these data, 180 daily food intake was similar between the groups ( Figure 4F ). In addition to their 181 fundamental role in energy balance, POMC neurons have been shown to be involved 182 in the regulation of peripheral glucose homeostasis (5, 6) . Accordingly, we also Cre;Efnb1 loxP/0 mice ( Figure 5J ). We also performed pyruvate and insulin tolerance 202 tests, and the results were identical in control and mutant mice (Figures S4D and 203 S4E) . Notably, similar metabolic disturbances were found in Pomc-Cre;Efnb1 loxP/loxP 204 female mice ( Figure S4 ). Together, these data show that mice lacking Efnb1 in 205 POMC neurons develop glucose intolerance that is associated with impaired insulin 206 secretion and impaired parasympathetic nerve activity. 207 208
Lack of Efnb2 in POMC neurons impairs feeding and gluconeogenesis in a sex-209 specific manner 210
To study the role of Efnb2 in the development of glutamatergic synapses in 211 POMC neurons, we crossed Efnb2 loxP mice (25) with Pomc-Cre mice. As expected, 212 the level of Efnb2 mRNA was significantly reduced in the ARH of Pomc-213
Cre;Efnb2 loxP/loxP mice, whereas the level of Efnb1 mRNA was unchanged between 214 mutant and control mice ( Figures 6A and 6B ). Efnb2 mRNA was also detected in 215 adeno-pituitary during late fetal and adult life ( Figure S4A and S5A). However, no 216 change was observed in Efnb2 mRNA expression in the pituitaries of mice that lack 217
Efnb2 in their POMC cells when compared to control mice ( Figure S5A ). 218
The lack of Efnb2 in POMC neurons affected glutamatergic inputs into POMC 219 neurons, with a 55% decrease in the number of vGLUT2-positive terminals that were 220 Together, these results suggest that the lack of Efnb2 in POMC neurons 232 impairs gluconeogenesis in males and it impairs food intake in a refeeding paradigm 233 in females. 234
Discussion 235
Energy and glucose homeostasis are tightly controlled by the brain. POMC 236 and AgRP/NPY neurons in the ARH are key regulators of these functions and 237 respond to peripheral signals through projections to second-order neurons controlling 238 endocrine and autonomic nervous systems. However, POMC and AgRP/NPY 239 neurons also receive extensive inputs from a plethora of areas of the brain (18) and 240 are thus integrated in a complex neuronal network. Although our understanding of 241 the control of feeding behavior and glucose homeostasis has improved over the last 242 few decades, it is still largely unknown how central circuits that regulate POMC 243 activity and their associated functions are being assembled. 244
Here, we showed that there is an enrichment of EphrinB members in POMC 245 neurons when glutamatergic inputs develop, and we described the role of ephrin 246 signaling in the control of the amount of excitatory inputs. EphrinB1 and EphrinB2 247 appear to both control the number of glutamatergic terminals on POMC neurons; 248 however, they play a distinct role in controlling energy and glucose homeostasis. 249
These are interesting findings given that glutamatergic input pattern is impaired both 250 in mice lacking EphrinB1 and those lacking EphrinB2 in POMC neurons, suggesting 251 functional heterogeneity in POMC neuronal circuits. 252
The present study is in agreement with previous work performed in rats (20) 253 and it shows that in mice, the amount of glutamatergic inputs into arcuate POMC 254 neurons increases gradually after birth until weaning. During this important period of 255 neuronal connectivity formation, we showed that POMC neurons were enriched with 256 EphrinB1 and EphrinB2, two members of the ephrin family. These proteins enable 257 cell to cell contacts through interaction with EphA and EphB receptors to control axon 258 growth, synaptogenesis or synaptic plasticity. We focused our study on Ephb1 and 259 Ephb2 receptors because their interactions with EphrinB1 and EphrinB2 are well 260 described (21) and EphrinB members are known to play a key role in AMPA and 261 NMDA glutamate receptor recruitment, stabilization of glutamatergic synapses, and 262 control of the number of excitatory synapses (26, 27) . 263
Here, we used a developmental approach that interfered with excitatory 264 synaptic input formation to specifically assess the role of glutamatergic inputs in 265 POMC neurons in the control of energy and glucose homeostasis. We showed that 266 lacking EphrinB1 or EphrinB2 in POMC neurons reduces the amount of 267 glutamatergic input into these neurons. Interestingly, these two mouse models do not 268 have similar physiological outcomes, suggesting specificity in the establishment of 269 glutamatergic input patterns. We first hypothesized that these differences arose from 270 POMC heterogeneity, as distinct subsets of leptin receptor-, insulin receptor-and 271 serotonin receptor-expressing POMC neurons are linked to functional differences; 272 (28,29) however, our data showed that every detected POMC neuron expressed both 273
Efnb1 and Efnb2. Thus, the differential effects of Efnb1 and Efnb2 inactivation on 274 energy and glucose metabolism could stem from EphrinB favoring the formation of 275 presynaptic inputs arising from distinct areas. Indeed, several Eph receptors can 276 interact with EphrinB1 and EphrinB2 (21) with different affinities (30) and can also be 277 differentially expressed in areas known to project to POMC neurons. These aspects 278 of the study require further analysis. 279
The loss of Efnb1 in POMC neurons is associated with alterations in glucose 280 tolerance and losses of parasympathetic nerve activity and insulin secretion. These 281 findings are consistent with previous studies, which reported that affecting either 282 POMC signaling, circuits or POMC neuron survival leads to impaired glucose 283 homeostasis (10) (11) (12) . Surprisingly, loss of Efnb1 in POMC neurons does not perturb 284 food intake or body weight. Other studies have shown that ablation or inactivation of 285 arcuate POMC neurons (12, 31) as well as genetic deficiency in POMC (32,33) cause 286 hyperphagia and obesity. In addition, chemogenetic stimulation of POMC neurons 287 reduces food intake (34) as well as activation of POMC neurons projecting into the 288 PVH (23). Notably, the aforementioned studies cannot distinguish the effects of these 289 kinds of input from those related to the output to POMC neurons, and only a few 290 studies have focused on the effect of synaptic inputs onto POMC neurons. Indeed, 291 deletion of two glutamatergic NMDA receptor subunits (GluN2A and GluN2B) in 292 POMC neurons does not lead to changes in glucose homeostasis (35). The 293 functional effect of presynaptic input to POMC neurons can be mediated by both 294 another NMDA subunit and through AMPA receptors (36);, both cases are in 295 agreement with our data, in that they cannot distinguish which glutamatergic 296 receptors are predominantly involved. In some cases, POMC functions require long 297 or chronic chemogenetic activation (9, 12) , which could reflect the recruitment of 298 NMDA receptors alongside AMPA receptors, since Ca 2+ entry through AMPA 299 receptors precedes full activation of NMDA receptors (37). 300 POMC neurons are well known glucose-excited neurons that drive the 301 response in maintaining normal glycemia (16, 38) . Our findings may also suggest that 302 glutamatergic innervation of POMC neurons is required for their ability to sense 303 extracellular levels of glucose. This has been shown for NTS catecholamine neurons, 304 which sense glucose through a presynaptic mechanism that is dependent upon, 305 among other factors, glutamate release (39). Moreover, glucose sensing in POMC 306 neurons requires ATP-sensitive potassium (K ATP ) channels (16) and Kir6.2 KO mice 307 (preventing ATP-mediated closure of KATP channels) display an absence of 308 glutamatergic AMPA receptors (40). Finally, glucose induces glutamatergic synaptic 309 remodeling of POMC neurons, potentially regulating the sensitivity of melanocortin 310 system to hormonal and neuronal signals (41). Collectively these data link glucose 311 sensing and glutamatergic release. 312
The loss of Efnb2 in POMC neurons impaired gluconeogenesis in males and 313 food intake in females in a refeeding paradigm. These findings are surprising, as 314 chemogenetic activation and inhibition of arcuate POMC neurons repress and 315 increase hepatic glucose production, respectively. Interestingly, a lack of ephrin 316 expression has been shown to induce local reorganization of glutamatergic synaptic 317 inputs (42). The lack of EphrinB2 in POMC neurons could therefore affect the 318 number of excitatory terminals connecting to nearby AgRP neurons, which are known 319
to suppress hepatic glucose production through insulin action (7,8) and to promote 320 feeding (43). 321
Our findings also suggest sexual dimorphism in the melanocortin system, as 322 the lack of Efnb2 in POMC neurons does not lead to impaired gluconeogenesis in 323 females, but it does result in changes to refeeding after an overnight fast. The ARH 324
has not been primarily viewed as a dimorphic structure, but recent studies showed 325 differences between males and females in the number of ARH POMC neurons, their 326 firing rate, the development of diet-induced obesity and the activation of STAT3 in 327 POMC neurons (44) (45) (46) . 328
The phenotypes we observed in mice lacking Efnb1 or Efnb2 can also be due 329 to synaptic plasticity, as cells with EphrinB have been shown to control this function 330
(27) and are found in the brains of adult animals (Allen Mouse Brain Atlas, 2004; (47) . 331
Moreover, hormones (8,17), metabolic status, physical activity (48) and the age (49) 332
can directly modulate the amount of glutamatergic and GABAergic synaptic inputs 333 into POMC neurons. 334
In conclusion, our data show that distinct Ephrin members control the 335 glutamatergic innervation of POMC neurons and specific functions such as glucose 336 homeostasis or feeding. This supports the idea that POMC neuronal network is 337
heterogeneous and that POMC neurons should not be considered as first-order 338 neurons but have to be thought predominantly as integrators of multiple kinds of 339 complex peripheral and central information to control energy and glucose 340 homeostasis. 341
Materials and Methods 342

Experimental Model and Subject Details 343
Studies in mice 344
All experimental procedures were approved by the Veterinary Office of Canton de 345
Vaud. Mice were group housed in individual cages and maintained in a temperature-346 controlled room with a 12hr light/dark cycle and provided ad libitum access to water 347 and standard laboratory chow (Kliba Nafag). Mice were single housed only for food 348 intake experiments. 349
All mice used in this study have been previously described: Pomc-Cre (23) EnvA-SADdG-mcherry alone. One week later, mice were anesthetized and perfused 369 with 4% PFA and frozen for brain cryosectioning. were microdissected under binocular loupe and enzymatically dissociated using the 374
Papain Dissociation System (Worthington) following the manufacturer's instructions. 375
Fluorescence-Activated Cell Sorting (FACS) was performed using a BD FACS Aria II 376
Cell Sorter to sort Pomc-tdTomato + , Npy-hrGFP + and cells containg both Pomc-377 tdTomato and Npy-hrGFP. Non-fluorescent cells obtained from wild-type animals 378 were used to set the gate of sorting. 379 380
Nucleus microdissection 381
As already described (52), PVH and ARH nuclei were microdissected under 382 binocular loupe from 200 µm-thick brain sections collected from P8, P10, P12, P14, 383 P16, and P18 C57Bl/6 pups (n=2-4/age, from at least 2 litters/age) and from 16 384
week-old Pomc-Cre;Efnb2 loxP/loxP and Efnb2 loxP/loxP . Microdissected nuclei were stored 385 at -80°C until RNA extraction using Picopure RNA extraction kit (Applied 386 Biosystems). 387
388
RNA-sequencing 389
RNAs were extracted from each sorted cell population using a Picopure RNA 390 extraction kit (Thermofischer Scientific). RNA integrity and concentration were 391 assessed with a 2100 Bioanalyser (Agilent). 500 picograms of RNAs were reverse 392 transcript using SMART-Seq v4 Ultra Low Input RNA (Takara) and RNA-seq librairies 393 were prepared the Illumina Nextera XT DNA Library kit (Illumina All assays were performed using an Applied Biosystems 7500 Fast real-time PCR 432 system. Calculations were performed by comparative method (2-ΔΔCT). 433
434
In vitro assay 435 P8 to P11 Pomc-eGFP male and female were used for the in vitro study. After brain 436 collection, PVH-and ARH-containing areas were microdissected under binocular 437 loupe. Cells were dissociated using the Papain Dissociation System (Worthington) 438 following the manufacturer's instructions. After dissociation, 40'000 cells from a mix 439 of PVH and ARH cells (ratio 1:1.2 to 1.4) were plated in poly-L-lysine coated 440 coverslip in 24-well plates containing Neurobasal medium supplemented with 1X 441 B27, 200mM glutamine, 1X penicillin/streptomycin. One hour later, medium was 442 changed and plates were incubated for a week at 37°C under 5% CO2 before weekly 443 changing the medium. After 25-28 days in vitro (DIV), cultures were exposed to 50nM 444 of ON-Target plus Mouse Efnb1 siRNA (J-051250-10-0002, #13642, Dharmacon), 445 ON-Target plus Mouse Efnb2 siRNA (J-051250-09-0002, #13641, Dharmacon) or 446 ON-Target plus Non-targeting Pool control siRNA (D-001810-10-05, Dharmacon) and 447 lipofectamine 2000 (Thermo scientific). After 3 days, cells were either fixed for 30min 448 with 4% paraformaldehyde in PBS or collected for RNA extraction and RT-qPCR to 449 assess siRNA-silencing efficiency. Cells were then incubated in rabbit anti-vGLUT2 450
(1:500, Synaptic Systems) and chicken anti-GFP (1:500, Abcam) for 2 days at 4°C. 451
The primary antibodies were visualized with Alexa goat anti-rabbit 568 and Alexa 452 goat anti-chicken 488. Coverslips were then mounted with DAPI fluoromount. Cre;tdTomato;Efnb2 loxP/loxP , Pomc-Cre;tdTomato female mice were transcardially 470 perfused with 4% PFA (n=3/group). 20 µm-thick brain and pancreas sections were 471 processed for immunofluorescence using standard procedures (10, 52, 58) . The 472 primary antibodies used for IHC were as follows: rabbit anti-vGLUT2 (1:500, Synaptic 473 Systems), rabbit anti-VAChT (1:500, Synaptic Systems), guinea-pig anti-insulin 474
(1:500, Abcam). Primary antibody was visualized with Alexa anti-rabbit 647 and 568 475
and Alexa anti-guinea-pig 488. 476 477
Images analyses 478
To quantitatively analyze cholinergic (VAChT-positive) fibers in pancreatic cells, 479 between 16 and 27 pancreatic islets per animal were imaged using a Zeiss LSM 710 480 confocal system equipped with a 20X objective. Each image was binarized to isolate 481 labeled fibers from the background and to compensate for differences in 482 fluorescence intensity. The integrated intensity, which reflects the total number of 483 pixels in the binarized image, was then calculated for each islet. This procedure was 484 conducted for each image. Image analysis was performed using Image J analysis 485 software (NIH). 486
To quantitatively analyze glutamatergic innervation of POMC neurons, adjacent 487 image planes were collected in lateral part of the ARH through the z-axis using a 488
Zeiss LSM 710 confocal system at a frequency of 0.25 µm through the entire 489 thickness of the ARH. Three-dimensional reconstructions of the image volumes were 490 then prepared using Imaris 9.3.1 visualization software. The number of glutamatergic 491 inputs into POMC neurons was quantified. Each putative glutamatergic input was 492 defined as a spot, and we quantified the number of glutamatergic spots that 493 contacted Pomc- Cre; tdtomato+. 494 
Physiological measures 495
Pomc-Cre;tdTomato;Efnb1 loxP/0 , Efnb1 loxP/0 (n = 14-16 per group), Pomc-496
Cre;tdTomato;Efnb2 loxP/loxP , Efnb2 loxP/loxP (n = 11-14 per group) male and Pomc-497
Cre;tdTomato;Efnb1 loxP/loxP , Efnb1 loxP/loxP (n = 8-10 per group),
Pomc-498
Cre;tdTomato;Efnb2 loxP/loxP , Efnb2 loxP/loxP female mice (n = 19 per group) were 499 weighed every week from 3 weeks (weaning) to 16 weeks using an analytical 500 balance.
To measure food consumption, 13-14-week-old Pomc-501
Cre;tdTomato;Efnb1 loxP/0 , Efnb1 loxP/0 (n = 9-12 per group),
Pomc-502
Cre;tdTomato;Efnb2 loxP/loxP , Efnb2 loxP/loxP (n = 6-10 per group) male mice and Pomc-503
Cre;tdTomato;Efnb2 loxP/loxP , Efnb2 loxP/loxP (n = 8 per group) female mice were housed 504 individually in BioDAQ cages (Research Diets), and, after at least 2 days of 505 acclimation, food intake was assessed on 2 consecutive days. The means obtained 506 on these 2 days were used for analyses. Body composition analysis (fat/lean mass) 507 was performed in 16-week-old Pomc-Cre;tdTomato;Efnb1 loxP/0 , Efnb1 loxP/0 (n = 9-10 508 per group), Pomc-Cre;tdTomato;Efnb2 loxP/loxP , Efnb2 loxP/loxP (n = 7-12 per group) male 509 mice and Pomc-Cre;tdTomato;Efnb2 loxP/loxP , Efnb2 loxP/loxP (n = 6 per group) female 510 mice using NMR (Echo MRI). Glucose (GTT), insulin (ITT) and pyruvate (PTT) 511 tolerance tests were conducted in 8-to 12 week-old Pomc-Cre;tdTomato;Efnb1 loxP/0 , 512 Efnb1 loxP/0 (n = 9-14 per group), Pomc-Cre;tdTomato;Efnb2 loxP/loxP , Efnb2 loxP/loxP (n = 513 8-13 per group) male mice and Pomc-Cre;tdTomato;Efnb2 loxP/loxP , Efnb2 loxP/loxP (n = 8-514 14 per group) female mice through i.p. injection of glucose (2 mg/g body weight), 515 insulin (0.5 U/kg body weight) or sodium pyruvate (2 mg/g body weight) after 516 overnight fasting (15h-16h, GTT and PTT) or 5-6 h of fasting (ITT). Blood glucose 517 levels were measured at 0, 15, 30, 45, 60, 90 , and 120 min post-injection. Glycemia 518 was measured using a glucometer (Bayer). 519
Glucose-stimulated insulin secretion tests were also performed at 9-10 weeks of age, 520 through the i.p. administration of glucose (2 mg/kg body weight, n = 6-12 per group) 521 after 15-16h overnight fasting. Blood samples were collected 0, 15 min and 0 and 30 522 min after glucose injection on 2 distinct cohortes. Serum insulin levels were then 523 measured using an insulin ELISA kit (Mercodia). Basal insulinemia was measured on 524 16-18 week-old mice (n=6-12/group) using an insulin ELISA kit (Mercodia).Basal 525 glycemia was measured the morning on fed mice using a glucometer (Bayer). 526 527
Vagus nerve activity recording 528
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